Value through Innovation27 July 2016

What is a lay summary?

To view this video in other translations click on the language below:
Chinese (simplified)
Chinese (traditional)
Portuguese (Brazilian)

Clinical Study Results

  • INFLAMMIDE ® - Asthma
    Clinical Study Number 1047.16
    Study Indication Asthma
    Product INFLAMMIDE ®
    Generic Name Budesonide
    Lab Code
    Clinical Phase IIIa
    Study Title

    A Randomised Double-Blind, Double-Dummy, Parallel Group Design.Twelve-week, Efficacy and Safety Study Comparing Respimat ® Budesonide (100 and 200 mcg, 2 puffs bid) with Turbohaler® Budesonide (200 mcg, 2 puffs bid) in Symptomatic Adult Moderate to Severe Asthmatics Requiring Inhaled Corticosteroids and Bronchodilator Therapy.

    Study Document
    Trial synopsis 1047.16 english